67
Views
4
CrossRef citations to date
0
Altmetric
Review

Novel nonpharmacologic approaches for stroke prevention in atrial fibrillation: results from clinical trials

, , , , , , , , & show all
Pages 103-114 | Published online: 29 Jan 2015

References

  • CammAJKirchhofPLipGYEuropean Heart Rhythm Association; European Association for Cardio-Thoracic SurgeryGuidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)Eur Heart J201031192369242920802247
  • SannaTDienerHCPassmanRSCRYSTAL AF InvestigatorsCryptogenic stroke and underlying atrial fibrillationN Engl J Med2014370262478248624963567
  • MohammedIMohmand-BorkowskiABurkeJFKoweyPRStroke prevention in atrial fibrillationJ Cardiovasc Med (Hagerstown)2012132738522193836
  • ContractorTKhasnisALeft Atrial Appendage Closure in Atrial Fibrillation: A World without Anticoagulation?Cardiol Res Pract2011201175280821559225
  • HartRGPearceLAAguilarMIMeta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillationAnn Intern Med20071461285786717577005
  • LeithäuserBParkJWCardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendageKorean Circ J2009391144345819997539
  • RashADownesTPortnerRYeoWWMorganNChannerKSA randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)Age Ageing200736215115617175564
  • MantJHobbsFDFletcherKBAFTA investigators; Midland Research Practices Network (MidReC)Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trialLancet2007370958649350317693178
  • ConnollySJPogueJHartRGACTIVE InvestigatorsEffect of clopidogrel added to aspirin in patients with atrial fibrillationN Engl J Med2009360202066207819336502
  • ConnollySPogueJHartRACTIVE Writing Group of the ACTIVE InvestigatorsClopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trialLancet200636795261903191216765759
  • EikelboomJWWallentinLConnollySJRisk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trialCirculation2011123212363237221576658
  • PatelMRMahaffeyKWGargJROCKET AF InvestigatorsRivaroxaban versus warfarin in nonvalvular atrial fibrillationN Engl J Med20113651088389121830957
  • GrangerCBAlexanderJHMcMurrayJJARISTOTLE Committees and InvestigatorsApixaban versus warfarin in patients with atrial fibrillationN Engl J Med20113651198199221870978
  • GiuglianoRPRuffCTBraunwaldEENGAGE AF-TIMI 48 InvestigatorsEdoxaban versus warfarin in patients with atrial fibrillationN Engl J Med2013369222093210424251359
  • GalanisTThomsonLPalladinoMMerliGJNew oral anticoagulantsJ Thromb Thrombolysis201131331032021327511
  • KwongJSLamYYYanBPYuCMBleeding of new oral anticoagulants for stroke prevention in atrial fibrillation: a meta-analysis of randomized controlled trialsCardiovasc Drugs Ther2013271233523224686
  • HeidbuchelHVerhammePAlingsMEHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summaryEur Heart J201334272094210623625209
  • HolsterILValkhoffVEKuipersEJTjwaETNew oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysisGastroenterology2013145110511223470618
  • BlackshearJLOdellJAAppendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillationAnn Thorac Surg19966127557598572814
  • SickPBSchulerGHauptmannKEInitial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillationJ Am Coll Cardiol200749131490149517397680
  • WhitlockRPHealeyJSConnollySJLeft atrial appendage occlusion does not eliminate the need for warfarinCirculation2009120191927193219901203
  • DouglasYLJongbloedMRGittenberger-de GrootACHistology of vascular myocardial wall of left atrial body after pulmonary venous incorporationAm J Cardiol200697566267016490434
  • Di BiaseLSantangeliPAnselminoMDoes the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter studyJ Am Coll Cardiol201260653153822858289
  • Al-SaadyNMObelOACammAJLeft atrial appendage: structure, function, and role in thromboembolismHeart199982554755410525506
  • NarumiyaTSakamakiTSatoYKanmatsuseKRelationship between left atrial appendage function and left atrial thrombus in patients with nonvalvular chronic atrial fibrillation and atrial flutterCirc J2003671687212520155
  • OnalanOCrystalELeft atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillationStroke200738(2) (Suppl)62463017261703
  • BayardYLOstermayerSHHeinRPercutaneous devices for stroke preventionCardiovasc Revasc Med20078321622517765654
  • NakaiTLeshMDGerstenfeldEPVirmaniRJonesRLeeRJPercutaneous left atrial appendage occlusion (PLAATO) for preventing cardioembolism: first experience in canine modelCirculation2002105182217222211994258
  • SievertHLeshMDTrepelsTPercutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experienceCirculation2002105161887188911997272
  • OstermayerSHReismanMKramerPHPercutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trialsJ Am Coll Cardiol200546191415992628
  • StöllbergerCFinstererJSchneiderBDoes percutaneous closure of the left atrial appendage prevent stroke in atrial fibrillation?J Am Coll Cardiol 420064771500
  • BayardYLOmranHNeuzilPPLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO studyEuroIntervention20106222022620562072
  • GageBFvan WalravenCPearceLSelecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirinCirculation2004110162287229215477396
  • BlockPCBursteinSCasalePNPercutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) StudyJACC Cardiovasc Interv20092759460019628179
  • ParkJWLeithäuserBGerkUVrsanskyMJungFPercutaneous left atrial appendage transcatheter occlusion (PLAATO) for stroke prevention in atrial fibrillation: 2-year outcomesJ Invasive Cardiol200921944645019726815
  • UssiaGPMulèMCammalleriVPercutaneous closure of left atrial appendage to prevent embolic events in high-risk patients with chronic atrial fibrillationCatheter Cardiovasc Interv200974221722219472361
  • LealSMorenoRde Sousa AlmeidaMSilvaJALopez-SendonJLEvidence-based percutaneous closure of the left atrial appendage in patients with atrial fibrillationCurr Cardiol Rev201281374222845814
  • HolmesDRReddyVYTuriZGPROTECT AF InvestigatorsPercutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trialLancet2009374968953454219683639
  • ReddyVYDoshiSKSievertHPROTECT AF InvestigatorsPercutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) TrialCirculation2013127672072923325525
  • BaiRHortonRPDI BiaseLIntraprocedural and long-term incomplete occlusion of the left atrial appendage following placement of the WATCHMAN device: a single center experienceJ Cardiovasc Electrophysiol201223545546122082312
  • Viles-GonzalezJFKarSDouglasPThe clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudyJ Am Coll Cardiol2012591092392922381428
  • AlliODoshiSKarSQuality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillationJ Am Coll Cardiol201361171790179823500276
  • GangireddySRHalperinJLFusterVReddyVYPercutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefitEur Heart J201233212700270823008509
  • ReddyVYMöbius-WinklerSMillerMALeft atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)J Am Coll Cardiol201361252551255623583249
  • MaiselWHLeft atrial appendage occlusion – closure or just the beginning?N Engl J Med2009360252601260319474420
  • HolmesDRJrKarSPriceMJProspective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trialJ Am Coll Cardiol201464111224998121
  • ParkJWBethencourtASievertHLeft atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experienceCatheter Cardiovasc Interv201177570070620824765
  • LamYYYipGWYuCMLeft atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experienceCatheter Cardiovasc Interv201279579480021542102
  • Lopez-MinguezJREldoayen-GrageraJGonzalez-FernandezRImmediate and One-year Results in 35 Consecutive Patients After Closure of Left Atrial Appendage With the Amplatzer Cardiac PlugRev Esp Cardiol2013662909724775381
  • UrenaMRodés-CabauJFreixaXPercutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapyJ Am Coll Cardiol20136229610223665098
  • Munkholm-LarsenSCaoCYanTDPehrsonSDixenUPercutaneous atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: a systematic reviewHeart2012981290090722511532
  • FreixaXAbualsaudAChanJLeft atrial appendage occlusion: initial experience with the Amplatzer™ Amulet™Int J Cardiol2014174349249624820753
  • LeeRJBartusKYakubovSJCatheter-based left atrial appendage (LAA) ligation for the prevention of embolic events arising from the LAA: initial experience in a canine modelCirc Cardiovasc Interv20103322422920484100
  • FisherDCTunickPAKronzonILarge gradient across a partially ligated left atrial appendageJ Am Soc Echocardiogr19981112116311659923999
  • KatzESTsiamtsiourisTApplebaumRMSchwartzbardATunickPAKronzonISurgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiograhic studyJ Am Coll Cardiol200036246847110933359
  • BenussiSMazzonePMaccabelliGThoracoscopic appendage exclusion with an atriclip device as a solo treatment for focal atrial tachycardiaCirculation2011123141575157821482976
  • BruceCJStantonCMAsirvathamSJPercutaneous epicardial left atrial appendage closure: intermediate-term resultsJ Cardiovasc Electrophysiol2011221647020662983
  • FriedmanPAAsirvathamSJDalegraveCPercutaneous epicardial left atrial appendage closure: preliminary results of an electrogram guided approachJ Cardiovasc Electrophysiol200920890891519368585
  • BartusKBednarekJMycJFeasibility of closed-chest ligation of the left atrial appendage in humansHeart Rhythm20118218819321050893
  • BartusKHanFTBednarekJPercutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experienceJ Am Coll Cardiol201362210811823062528
  • StoneDByrneTPershadAEarly Results With the LARIAT Device for Left Atrial Appendage Exclusion in Patients With Atrial Fibrillation at High Risk for Stroke and AnticoagulationCatheter Cardiovasc Interv2013 n/a
  • HanFTBartusKLakkireddyDThe effects of LAA ligation on LAA electrical activityHeart Rhythm201411586487024444443
  • CammAJLipGYDe CaterinaRESC Committee for Practice Guidelines (CPG)2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm AssociationEur Heart J201233212719274722922413
  • JanuaryCTWannLSAlpertJS2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm SocietyJ Am Coll Cardiol Epub3282014
  • ChengYMcGregorJEdmistonDLong-term safety and biocompatibility of the Coherex WaveCrest™ left atrial appendage occluder in a canine modelJ Am Coll Cardiol20146310.1016/S0735-1097(14)61680-61686
  • ChengYMcGregorJSommerRTCT-764 Safety and Biocompatibility of the Coherex WaveCrest™ Left Atrial Appendage Occluder in a 30-Day Canine StudyJ Am Coll Cardiol20126017_S10.1016/j.jacc.2012.08.807
  • ReddyVYHolmesDDoshiSKNeuzilPKarSSafety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access RegistryCirculation2011123441742421242484
  • Di BiaseLBurkhardtJDMohantyPLeft atrial appendage: an underrecognized trigger site of atrial fibrillationCirculation2010122210911820606120
  • StöllbergerCSchneiderBFinstererJElimination of the left atrial appendage to prevent stroke or embolism? Anatomic, physiologic, and pathophysiologic considerationsChest200312462356236214665520
  • MeierBPalaciosIWindeckerSTranscatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillationCatheter Cardiovasc Interv200360341742214571497